ORGANON & CO. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.52 USD | -0.60% |
|
+4.92% | +49.24% |
| May. 08 | Organon Reports Pricing of $1 Billion Senior Notes Offering | MT |
| May. 08 | Organon & Co. and Organon Foreign Debt Co-Issuer B.V. Announces Pricing of $1.0 Billion Senior Notes Offering | CI |
Chart calendar Organon & Co.
1a4502be1cf8d.DDxh81EbVLET2aYpeJge9ipHqOcG4rYbqobF9oSWHKQ.W1otpjVqA8NFlJB-DtVpnWEY4YpFl88pwsD1z-e7X_5KbAW3JCM6w1CQ8w~e0650ef66a98cd776f390cc31bef0445
Upcoming events on Organon & Co.
Past events on Organon & Co.
| 2024-05-02 08:30 am | Q1 2024 Earnings Call |
| 2024-05-02 07:30 am | Q1 2024 Earnings Release |
| 2024-02-15 08:30 am | Q4 2023 Earnings Call |
| 2024-02-15 07:30 am | Q4 2023 Earnings Release |
| 2024-01-09 04:30 pm | JPMorgan Healthcare Conference |
| 2023-11-29 11:00 am | Piper Sandler Healthcare Conference - Fireside Chat |
| 2023-11-02 08:30 am | Q3 2023 Earnings Call |
| 2023-11-02 07:30 am | Q3 2023 Earnings Release |
| 2023-08-08 08:30 am | Q2 2023 Earnings Call |
| 2023-08-08 07:30 am | Q2 2023 Earnings Release |
| 2023-06-06 09:00 am | Annual General Meeting |
| 2023-05-04 08:30 am | Q1 2023 Earnings Call |
| 2023-05-04 07:30 am | Q1 2023 Earnings Release |
| 2023-02-16 08:30 am | FY 2022 Earnings Call |
| 2023-02-16 07:30 am | FY 2022 Earnings Release |
| 2023-01-10 10:30 am | JP Morgan Healthcare Conference - Fireside Chat |
| 2022-11-29 09:00 am | Piper Sandler Healthcare Conference - Fireside Chat |
| 2022-11-03 08:30 am | Q3 2022 Earnings Call |
| 2022-11-03 07:30 am | Q3 2022 Earnings Release |
| 2022-08-04 08:30 am | Interim 2022 Earnings Call |
Past dividends on Organon & Co.
| 2024-05-09 | Quarterly 0.28 USD |
| 2024-02-22 | Quarterly 0.28 USD |
| 2023-11-09 | Quarterly 0.28 USD |
| 2023-08-16 | Quarterly 0.28 USD |
| 2023-05-11 | Quarterly 0.28 USD |
| 2023-02-23 | Quarterly 0.28 USD |
| 2022-11-09 | Quarterly 0.28 USD |
| 2022-08-11 | Quarterly 0.28 USD |
| 2022-05-12 | Quarterly 0.28 USD |
| 2022-02-24 | Quarterly 0.28 USD |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 8 096 | 6 304 6 280 0.38% | 6 174 6 186 -0.19% | 6 263 6 214 0.79% | 6 391 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 2 379 2 287 4.01% | 2 085 2 104 -0.91% | 1 944 1 921 1.22% | 2 055 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | 2 184 2 239 -2.48% | 1 873 1 971 -4.99% | 1 874 1 803 3.93% | 1 930 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | 1 529 1 712 -10.69% | 1 122 1 173 -4.35% | 673 929 -27.56% | 933 |
|
Net income Million USD | Released Forecast Spread | 2 160 | 1 351 1 484 -8.96% | 917 941 -2.55% | 1 023 602 69.93% | 751 |
|
EPS USD | Released Forecast Spread | 0,00 | 5,31 5,98 -11.2% | 3,59 3,71 -3.15% | 3,99 2,35 69.79% | 2,90 |
| Announcement Date | 14/04/21 | 17/02/22 | 16/02/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1 567 1 519 3.14% | 1 585 1 532 3.49% | 1 537 1 516 1.39% | 1 485 1 495 -0.7% | 1 538 1 538 -0.02% | 1 608 1 557 3.3% | 1 519 1 572 -3.39% | 1 598 1 481 7.87% | 1 622 1 560 3.96% | 1 627 | 1 556 | 1 573 | 1 570 | 1 609 |
|
EBITDA Million USD | Released Forecast Spread | 647 512 26.38% | 512 474 8.1% | 546 469 16.52% | 380 423 -10.21% | 518 535 -3.26% | 530 462 14.7% | 447 493 -9.4% | 449 412 8.96% | 538 442 21.72% | 531 | 509 | 507 | ||
|
EBIT Million USD | Released Forecast Spread | 594 501 18.51% | 462 456 1.35% | 489 446 9.54% | 328 398 -17.56% | 461 487 -5.3% | 472 438 7.69% | 430 468 -8.03% | 436 405 7.67% | 475 438 8.47% | 506 | 475 | 473 | 495 | 505 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 287 348 -17.53% | 282 256 10.16% | 111 170 -34.71% | 235 282 -16.67% | 254 275 -7.64% | 80,0 238 -66.39% | 104 202 -48.51% | |||||||
|
Net income Million USD | Released Forecast Spread | 234 284 -17.61% | 227 209 8.61% | 108 139 -22.3% | 177 226 -21.68% | 242 220 10% | 58,0 191 -69.63% | 546 162 237.04% | |||||||
|
EPS USD | Released Forecast Spread | 1,36 0,98 38.78% | 0,92 0,92 0.55% | 0,89 0,82 8.54% | 0,42 0,56 -25% | 0,69 0,95 -27.37% | 0,95 0,86 10.47% | 0,23 0,74 -68.92% | 2,13 0,63 238.1% | ||||||
| Announcement Date | 05/05/22 | 04/08/22 | 03/11/22 | 16/02/23 | 04/05/23 | 08/08/23 | 02/11/23 | 15/02/24 | 02/05/24 | - | - | - | - | - |
More events
Past sector events for Organon & Co.
| Today | J. B. CHEMICALS & PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| Today | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 10:05 am | MANKIND PHARMA LIMITED: Q4 2024 Earnings Release |
| 2024-05-15 01:30 am | DERMAPHARM HOLDING SE: Q1 2024 Earnings Release |
| 2024-05-15 07:40 am | CRESCO LABS INC.: Q1 2024 Earnings Release |
| 2024-05-15 03:03 am | GRANULES INDIA LIMITED: Q4 2024 Earnings Release |
| 2024-05-14 | EISAI CO., LTD.: Q4 2023 Earnings Release |
| 2024-05-14 05:43 pm | LIQUIDIA CORPORATION: Q1 2024 Earnings Release |
| 2024-05-14 04:52 am | BORA PHARMACEUTICALS CO., LTD.: Q1 2024 Earnings Release |
| 2024-05-14 01:30 am | BAYER AG: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OGN Stock
- Calendar Organon & Co.
